TEVA PHARMACEUTICAL INDUSTRIES LTD Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Teva Pharmaceutical Industries Ltd quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Teva Pharmaceutical Industries Ltd Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $364M, a 10.3% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $364M -$42M -10.3% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $358M -$60M -14.4% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $364M -$56M -13.3% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $397M -$22M -5.25% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $406M -$16M -3.79% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $418M -$23M -5.22% Jun 30, 2023 10-Q 2023-08-02
Q1 2023 $420M -$44M -9.48% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $419M -$76M -15.4% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $422M -$85M -16.8% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $441M -$90M -16.9% Jun 30, 2022 10-Q 2022-07-27
Q1 2022 $464M -$65M -12.3% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $495M -$64M -11.4% Dec 31, 2021 10-K 2023-02-10
Q3 2021 $507M -$50M -8.98% Sep 30, 2021 10-Q 2021-10-27
Q2 2021 $531M +$42M +8.59% Jun 30, 2021 10-Q 2021-07-28
Q1 2021 $529M +$40M +8.18% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $559M +$45M +8.76% Dec 31, 2020 10-K 2022-02-09
Q3 2020 $557M +$89M +19% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $489M -$11M -2.2% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $489M -$28M -5.42% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $514M Dec 31, 2019 10-K 2021-02-10
Q3 2019 $468M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $500M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $517M Mar 31, 2019 10-Q 2019-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.